Seeing Is Believing

Currently out of the existing stock ratings of Lee Hambright, 17 are a HOLD (39.53%), 25 are a BUY (58.14%), 1 are a SELL (2.33%).
Analyst Lee Hambright, currently employed at BERNSTEIN, carries an average stock price target met ratio of 75.19% that have a potential upside of 20.08% achieved within 316 days. Previously, Lee Hambright worked at CREDIT SUISSE.
Lee Hambright’s has documented 86 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABT, Abbott Laboratories at 09-Jan-2026.
Analyst best performing recommendations are on ISRG (INTUITIVE SURGICAL).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 7/13/2020. The price target of $208.33 was fulfilled within 4 days with a profit of $17.9 (9.4%) receiving and performance score of 23.5.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 25-Jul-2024
$97
$12.42 (14.68%)
$75
2 days ago
(09-Jan-2026)
14/18 (77.78%)
$12.42 (14.68%)
211
Buy
Since 30-Jan-2025
$105
$20.42 (24.14%)
$100
4 days ago
(07-Jan-2026)
15/22 (68.18%)
$20.17 (23.78%)
86
Hold
Since 25-Jul-2024
$100
$15.42 (18.23%)
$90
24 days ago
(18-Dec-2025)
5/10 (50%)
$14.68 (17.21%)
119
Hold
Since 14-Oct-2022
$87
$2.42 (2.86%)
$89
25 days ago
(17-Dec-2025)
17/23 (73.91%)
$1.68 (1.97%)
94
Hold
Since 25-Jul-2024
$87
$2.42 (2.86%)
$88
25 days ago
(17-Dec-2025)
9/14 (64.29%)
$1.68 (1.97%)
34
Which stock is Lee Hambright is most bullish on?
Which stock is Lee Hambright is most reserved on?
What Year was the first public recommendation made by Lee Hambright?